newsfilter
← Latest News
ACCESS Newswire·

Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe

PARIS, FRANCE / CAMBRIDGE, MA / ACCESSWIRE / August 8, 2023 / Biophytis SA , , a clinical-stage biotechnology company specialized in the development of therapeutics